Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Macrophages as novel target cells for erythropoietin
Lilach Lifshitz
, Galit Tabak
, Max Gassmann
,
Moshe Mittelman
,
Drorit Neumann
*
*
Corresponding author for this work
Medicine Dean & Assoc. Deans
Cell and Developmental Biology
Tel Aviv University
Tel Aviv Sourasky Medical Center
University of Zurich
Research output
:
Contribution to journal
›
Article
›
peer-review
93
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Macrophages as novel target cells for erythropoietin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Macrophages
100%
Erythropoietin
100%
Splenic Macrophages
23%
CD11b
23%
CD80
23%
Direct Target
23%
MHC Class II
15%
Phagocytic Activity
15%
Erythropoietin Receptor
15%
RhEPO
15%
Erythropoietin Therapy
15%
Transgenic Mice
7%
Immune System
7%
Lymphocytes
7%
Overexpressing
7%
Phosphoinositide 3-kinase (PI3K)
7%
In Vitro Experiment
7%
Mitogen-activated Protein Kinase
7%
Nitric Oxide
7%
Surface Expression
7%
Peritoneal Macrophages
7%
Lipopolysaccharide
7%
In Vivo Applications
7%
In Vitro Effect
7%
Bone Marrow Cells
7%
Nuclear factor-κB
7%
Multiple Myeloma
7%
Inflammatory Macrophages
7%
Interleukin-10
7%
Dendritic Cells
7%
In Vitro Activation
7%
Interleukin-12 (IL-12)
7%
Immunomodulatory Effect
7%
Surface Function
7%
Multiple Signaling Pathways
7%
Bone Marrow-derived Macrophages
7%
Human Erythropoietin
7%
Signal Transducer and Activator of Transcription 5
7%
Multifunctional Roles
7%
Signal Transducer and Activator of Transcription 1
7%
Macrophage Surface Markers
7%
Potential Clinical Applications
7%
Immunosuppressive Agents
7%
Murine Bone Marrow
7%
Pro-inflammatory Activity
7%
Immunology and Microbiology
Macrophage
100%
Target Cell
100%
Erythropoietin
100%
Secretion (Process)
18%
CD80
18%
Phagocytosis
12%
Major Histocompatibility Complex
12%
Erythropoietin Receptor
12%
Epoetin Beta
12%
Wild Type
6%
Mitogen
6%
Bone Marrow Cell
6%
Multiple Myeloma
6%
Interleukin 10
6%
Dendritic Cell
6%
Murine
6%
Transgenic Mouse
6%
Immunomodulating Drugs
6%
Immunoglobulin Enhancer Binding Protein
6%
Bone Marrow-Derived Macrophage
6%
STAT5
6%
STAT1
6%
Lymphocyte
6%
Interleukin 12
6%
Immune System
6%
Peritoneal Macrophage
6%
Biochemistry, Genetics and Molecular Biology
Target Cell
100%
Macrophage
100%
Erythropoietin
100%
Secretion (Process)
18%
CD80
18%
Erythropoietin Receptor
12%
Major Histocompatibility Complex
12%
Darbepoetin Alfa
12%
Phagocytosis
12%
Transgenic Mouse
6%
Wild Type
6%
Phosphoinositide 3-Kinase
6%
Mitogen-Activated Protein Kinase
6%
Murine
6%
In Vivo Study
6%
Interleukin 10
6%
Dendritic Cell
6%
Interleukin 12
6%
Nitric Oxide
6%
Immunoglobulin Enhancer Binding Protein
6%
STAT5
6%
STAT1
6%
Lymphocyte
6%
Lipopolysaccharide
6%
Veterinary Science and Veterinary Medicine
Macrophage
100%
Target Cell
100%
Erythropoietin
100%
Mouse
11%
Darbepoetin Alfa
11%
Dendritic Cell
5%
STAT5
5%
STAT1
5%
Lymphocyte
5%
Multiple Myeloma
5%
Transgenic Mouse
5%
Pharmacology, Toxicology and Pharmaceutical Science
Erythropoietin
100%
Recombinant Erythropoietin
12%
Erythropoietin Receptor
12%
Mitogen Activated Protein Kinase
6%
Multiple Myeloma
6%
Murine
6%
Interleukin 10
6%
Lipopolysaccharide
6%
Interleukin 12
6%
Transgenic Mouse
6%
Nitric Oxide
6%
Phosphatidylinositol 3 Kinase
6%
Immunomodulating Agent
6%
Immunoglobulin Enhancer Binding Protein
6%
STAT1 Protein
6%
STAT5 Protein
6%